University College London (UCL) ECMC is committed to performing world-class clinical cancer research to discover and develop new treatments and improve the outcome for patients. Our Centre integrates fundamental scientific advances with optimised patient care in high quality clinical research performed in a patient focused environment. Our Centre has expertise in the field of:
UCL has an extensive portfolio of cell based therapies including the most comprehensive CAR T-cell programme in Europe, encompassing a broad range portfolio of studies actively recruiting patients with B and T-cell malignancies, myeloma, HCC and neuroblastoma.
Our Centre has a vast porfolio of solid tumour trials including GI cancers, head and neck cancers, melanoma, liver, HCC, neuroendocrine, lung and gynaecological cancers. We also have a portfolio of rare cancers studies (sarcomas) which includes teenage and young adult patients. Our current portfolio of studies brings in close collaboration with 37 pharmaceutical companies.
Our Patient Population
Our clinical research facility serves a local population of 6M.
Number of patients treated: 156
Organisations affiliated with the UCL ECMC:
UCL ECMC is situated in London with easy access to a number of major railway stations and airports.
By tube: Euston, Euston Square, King's Cross, Russell Square and Warren Street
By National Rail: Euston, King's Cross and St. Pancras International
Ey Eurostar: St. Pancras International (Eurostart terminal)
By air: Heathrow, Gatwick, Stansted, Luton, London City Airport
Contact the Centre Manager: